| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Change Management > Organizational Change: How to Foster and Manage Change |
|
Advice You - Organizational Change: How to Foster and Manage Change
“It is not the strongest species that survives, nor the most intelligent, but the most responsive to change According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ”. - Charles Darwin The only constant in this world is change, even then the basic instinct of a human bei ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in g is to avoid change and to continue with status quo. So the prime question is how to motivate people to ch lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ange and how efficiently to manage change. Over the past decade managing change has become one of the bigge here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe t organizational challenges for corporate America. The aim today is to build an organization that can quick d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ly respond, innovate, and flex to changes on an ongoing basis. To fulfill this aim of building an ever chan ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ing and ever evolving future proof organization we analyzed five theories of change and in this paper we wi easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ll discuss how they can be implemented in the real world. Organizational Change Businesses are fas nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically changing and these changes vary from industry to industry. Technology is fast changing the space in which and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ companies use to operate and building a future proof organization structure is the key priority today for a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi y organization. The Establishment of Intra-Organizational Networks As organizations are growing b ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a gger than ever before, the task of managing and synchronizing organizational operations is coming under spo dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod tlight more than ever before. Influencing politics Influencing politics is referred to external f cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ctors which influence the change environment in the organization and these factors can’t be determined by t tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen he organization. The best a company can do is managing them. Generation of New Ideas and Different Prop t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel sals Innovation is the key to future growth and companies which will prosper in future are the one wh ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ich focus its most energy on research and development. Theory of Training Training helps people fo y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products future individual challenges, it also enhances employees motivation and prepare them for further change re . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de garding decisions in the organization. How each of these factors will influence the rate of change in the elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip nvironment and their relative influence on managing that change will be discussed in detail in next article tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:
|